Percutaneous Renal Denervation:Latest Evidence and Patient Selection
Despite the existence of numerous pharmacological and non-pharmacological interventions for lowering blood pressure,refractory hypertension persists as a significant health concern.Renal denervation(RDN)has become a promising and clinically proven instrument therapy method for improving blood pressure and increasing blood pressure control.This review summarizes the current understanding of the mechanisms behind RDN in treating hypertension and provides an overview of several randomized sham-controlled clinical studies on RDN,as well as optimization of patient selection.